来自MSN9 个月
Tempus wins FDA nod for AI-backed heart diagnostic
Based on recordings of 12-lead electrocardiogram (ECG) devices, the Tempus ECG-AF algorithm can detect the risk of a patient developing AF over the next 12 months. The company added that the ...
来自MSN1 个月
HeartBeam submits 510(k) application to FDA for ECG software
HeartBeam has submitted a 510(k) application to the US Food and Drug Administration (FDA) for its 12-lead electrocardiogram (ECG) synthesis software tailored to assess various cardiac rhythms and ...